BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lescoat A, Roofeh D, Townsend W, Hughes M, Sandler RD, Zimmermann F, Pauling JD, Buch MH, Khanna D. Domains and outcome measures for the assessment of limited cutaneous systemic sclerosis: a scoping review protocol. BMJ Open 2021;11:e044765. [PMID: 33707273 DOI: 10.1136/bmjopen-2020-044765] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Lescoat A, Murphy SL, Chen YT, Vann N, Galdo FD, Cella D, Buch MH, Khanna D. Symptom experience of limited cutaneous systemic sclerosis from the Patients' perspective: A qualitative study✰,✰✰,★,★★. Semin Arthritis Rheum 2021:S0049-0172(21)00199-2. [PMID: 34785028 DOI: 10.1016/j.semarthrit.2021.11.003] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Ruaro B, Confalonieri M, Salton F, Wade B, Baratella E, Geri P, Confalonieri P, Kodric M, Biolo M, Bruni C. The Relationship between Pulmonary Damage and Peripheral Vascular Manifestations in Systemic Sclerosis Patients. Pharmaceuticals (Basel) 2021;14:403. [PMID: 33922710 DOI: 10.3390/ph14050403] [Cited by in Crossref: 2] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]